SIMILAR PATTERNS OF AMINO ACIDS FOR 2VIN_A_505A1247_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1a0j | TRYPSIN (Salmo salar) |
PF00089(Trypsin) | 6 | ASP A 189SER A 190SER A 195VAL A 213GLY A 216GLY A 226 | BEN A 246 (-3.0A)BEN A 246 (-3.0A)SO4 A 248 ( 2.5A)NoneBEN A 246 ( 3.9A)BEN A 246 (-3.3A) | 0.25A | 2vinA-1a0jA:16.6 | 2vinA-1a0jA:37.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1a5i | PLASMINOGENACTIVATOR (Desmodusrotundus) |
PF00089(Trypsin) | 4 | ASP A 189SER A 195GLY A 216GLY A 226 | 0GJ A 245 (-3.1A)0GJ A 245 (-1.4A)0GJ A 245 (-3.5A)0GJ A 245 ( 4.2A) | 0.43A | 2vinA-1a5iA:36.3 | 2vinA-1a5iA:39.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1afq | BOVINEGAMMA-CHYMOTRYPSIN (Bos taurus) |
PF00089(Trypsin) | 5 | SER C 190SER C 195VAL C 213GLY C 216GLY C 226 | None0FG C 301 ( 3.0A)None0FG C 301 (-3.4A)0FG C 301 ( 4.4A) | 0.57A | 2vinA-1afqC:11.1 | 2vinA-1afqC:20.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1bqy | PLASMINOGENACTIVATOR (Trimeresurusstejnegeri) |
PF00089(Trypsin) | 5 | ASP A 189SER A 195VAL A 213GLY A 216GLY A 226 | 0GJ A 1 (-3.1A)0GJ A 1 ( 1.4A)None0GJ A 1 (-3.5A)0GJ A 1 ( 4.3A) | 0.48A | 2vinA-1bqyA:10.1 | 2vinA-1bqyA:32.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1bru | ELASTASE (Sus scrofa) |
PF00089(Trypsin) | 4 | SER P 190SER P 195VAL P 213GLY P 216 | 1NB P 1 (-3.5A)1NB P 1 ( 1.2A)None1NB P 1 ( 4.4A) | 0.54A | 2vinA-1bruP:37.1 | 2vinA-1bruP:36.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1dlk | THROMBIN HEAVY CHAIN (Bos taurus) |
PF00089(Trypsin) | 5 | SER B 190SER B 195VAL B 213GLY B 216GLY B 226 | None | 0.58A | 2vinA-1dlkB:35.7 | 2vinA-1dlkB:33.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ekb | ENTEROPEPTIDASE (Bos taurus) |
PF00089(Trypsin) | 5 | ASP B 189SER B 190SER B 195GLY B 216GLY B 226 | None | 0.29A | 2vinA-1ekbB:37.2 | 2vinA-1ekbB:34.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1elv | COMPLEMENT C1SCOMPONENT (Homo sapiens) |
PF00084(Sushi)PF00089(Trypsin) | 6 | ASP A 611SER A 612SER A 617VAL A 638GLY A 641GLY A 648 | NoneNoneSO4 A2001 ( 2.7A)NoneNoneNone | 0.37A | 2vinA-1elvA:31.0 | 2vinA-1elvA:24.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ept | PORCINE E-TRYPSIN (Sus scrofa) |
PF00089(Trypsin) | 6 | ASP C 189SER C 190SER C 195VAL C 213GLY C 216GLY C 226 | None | 0.28A | 2vinA-1eptC:12.9 | 2vinA-1eptC:24.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1euf | DUODENASE (Bos taurus) |
PF00089(Trypsin) | 4 | SER A 190SER A 195VAL A 213GLY A 216 | None | 0.37A | 2vinA-1eufA:12.5 | 2vinA-1eufA:34.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fi8 | NATURAL KILLER CELLPROTEASE 1 (Rattusnorvegicus) |
PF00089(Trypsin) | 4 | SER A 190SER A 195VAL A 213GLY A 216 | None | 0.31A | 2vinA-1fi8A:9.3 | 2vinA-1fi8A:32.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fiw | BETA-ACROSIN HEAVYCHAIN (Ovis aries) |
PF00089(Trypsin) | 4 | ASP A 189SER A 195GLY A 216GLY A 226 | PBZ A 305 (-2.7A)PBZ A 305 (-2.9A)PBZ A 305 (-3.4A)PBZ A 305 (-3.3A) | 0.34A | 2vinA-1fiwA:37.1 | 2vinA-1fiwA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fiz | BETA-ACROSIN HEAVYCHAIN (Sus scrofa) |
PF00089(Trypsin) | 4 | ASP A 189SER A 195GLY A 216GLY A 226 | PBZ A 308 (-2.9A)PBZ A 308 (-3.2A)PBZ A 308 (-3.6A)PBZ A 308 ( 3.7A) | 0.33A | 2vinA-1fizA:14.1 | 2vinA-1fizA:32.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fq3 | GRANZYME B (Homo sapiens) |
PF00089(Trypsin) | 4 | SER A 190SER A 195VAL A 213GLY A 216 | NoneSO4 A 800 (-2.4A)NoneNone | 0.70A | 2vinA-1fq3A:5.3 | 2vinA-1fq3A:32.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fxy | COAGULATION FACTORXA-TRYPSIN CHIMERA (Homo sapiens) |
PF00089(Trypsin) | 6 | ASP A 189SER A 190SER A 195VAL A 213GLY A 216GLY A 226 | 0G6 A 1 (-2.8A)0G6 A 1 (-2.8A)0G6 A 1 (-1.4A)None0G6 A 1 (-3.9A)0G6 A 1 (-3.3A) | 0.32A | 2vinA-1fxyA:10.6 | 2vinA-1fxyA:34.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gk2 | HISTIDINEAMMONIA-LYASE (Pseudomonasputida) |
PF00221(Lyase_aromatic) | 5 | ASP A 145SER A 200VAL A 334GLY A 329GLY A 141 | None | 1.04A | 2vinA-1gk2A:undetectable | 2vinA-1gk2A:19.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1gvl | KALLIKREIN 6 (Homo sapiens) |
PF00089(Trypsin) | 4 | SER A 195VAL A 213GLY A 216GLY A 226 | None | 0.63A | 2vinA-1gvlA:7.4 | 2vinA-1gvlA:38.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1h4w | TRYPSIN IVA (Homo sapiens) |
PF00089(Trypsin) | 6 | ASP A 189SER A 190SER A 195VAL A 213GLY A 216GLY A 226 | BEN A 250 (-2.9A)BEN A 250 (-2.9A)BEN A 250 (-3.6A)NoneBEN A 250 (-3.9A)BEN A 250 (-3.3A) | 0.27A | 2vinA-1h4wA:15.5 | 2vinA-1h4wA:38.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1h9h | TRYPSIN (Sus scrofa) |
PF00089(Trypsin) | 6 | ASP E 189SER E 190SER E 195VAL E 213GLY E 216GLY E 226 | None | 0.36A | 2vinA-1h9hE:10.8 | 2vinA-1h9hE:37.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1id5 | THROMBIN (Bos taurus) |
PF00089(Trypsin) | 5 | ASP H 189SER H 195VAL H 213GLY H 216GLY H 226 | None | 0.49A | 2vinA-1id5H:35.1 | 2vinA-1id5H:31.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1j17 | TRYPSIN II, ANIONIC (Rattusnorvegicus) |
PF00089(Trypsin) | 6 | ASP T 189GLN T 192SER T 195VAL T 213GLY T 216GLY T 226 | ZEN T 1 ( 3.8A)NoneSO4 T 600 ( 2.6A)ZEN T 1 (-4.1A)ZEN T 1 (-3.7A)ZEN T 1 (-3.7A) | 0.72A | 2vinA-1j17T:14.5 | 2vinA-1j17T:36.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1kig | FACTOR XA (Bos taurus) |
PF00089(Trypsin) | 5 | ASP H 189GLN H 192SER H 195VAL H 213GLY H 226 | None | 0.65A | 2vinA-1kigH:14.0 | 2vinA-1kigH:32.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1kig | FACTOR XA (Bos taurus) |
PF00089(Trypsin) | 5 | ASP H 189SER H 195VAL H 213GLY H 216GLY H 226 | None | 0.52A | 2vinA-1kigH:14.0 | 2vinA-1kigH:32.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1mbq | TRYPSIN (Oncorhynchusketa) |
PF00089(Trypsin) | 7 | ASP A 189SER A 190GLN A 192SER A 195VAL A 213GLY A 216GLY A 226 | BEN A1222 (-2.9A)BEN A1222 (-2.9A)NoneBEN A1222 (-3.5A)NoneBEN A1222 (-3.9A)BEN A1222 (-3.4A) | 0.41A | 2vinA-1mbqA:17.4 | 2vinA-1mbqA:34.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1mt5 | FATTY-ACID AMIDEHYDROLASE (Rattusnorvegicus) |
PF01425(Amidase) | 4 | SER A 193GLN A 189GLY A 402GLY A 485 | None | 0.73A | 2vinA-1mt5A:undetectable | 2vinA-1mt5A:17.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1npm | NEUROPSIN (Mus musculus) |
PF00089(Trypsin) | 5 | ASP A 189GLN A 192SER A 195GLY A 216GLY A 226 | None | 0.63A | 2vinA-1npmA:11.5 | 2vinA-1npmA:35.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1o5f | SERINE PROTEASEHEPSIN (Homo sapiens) |
PF00089(Trypsin) | 6 | ASP H 189GLN H 192SER H 195VAL H 213GLY H 216GLY H 226 | CR9 H 256 (-2.4A)CR9 H 256 ( 4.4A)CR9 H 256 (-1.5A)CR9 H 256 (-4.3A)CR9 H 256 ( 3.8A)CR9 H 256 (-3.0A) | 0.44A | 2vinA-1o5fH:36.2 | 2vinA-1o5fH:37.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ohf | NUDAURELIA CAPENSISOMEGA VIRUS CAPSIDPROTEIN (Nudaureliacapensis omegavirus) |
PF03566(Peptidase_A21) | 4 | SER A 303GLN A 326GLY A 492GLY A 490 | None | 0.74A | 2vinA-1ohfA:undetectable | 2vinA-1ohfA:17.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1op2 | VENOM SERINEPROTEINASE (Deinagkistrodonacutus) |
PF00089(Trypsin) | 5 | ASP A 189SER A 195VAL A 213GLY A 216GLY A 226 | None | 0.55A | 2vinA-1op2A:9.2 | 2vinA-1op2A:31.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1orf | GRANZYME A (Homo sapiens) |
PF00089(Trypsin) | 5 | ASP A 189SER A 190SER A 195GLY A 216GLY A 226 | 0G6 A 1 (-2.9A)0G6 A 1 (-2.9A)0G6 A 1 (-1.3A)0G6 A 1 (-3.3A)0G6 A 1 (-3.5A) | 0.40A | 2vinA-1orfA:10.7 | 2vinA-1orfA:29.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1pfx | FACTOR IXA (Sus scrofa) |
PF00089(Trypsin) | 6 | ASP C 189SER C 190GLN C 192SER C 195GLY C 216GLY C 226 | 0G6 C 301 (-3.0A)0G6 C 301 (-2.6A)None0G6 C 301 (-1.4A)0G6 C 301 (-3.2A)0G6 C 301 ( 3.5A) | 0.51A | 2vinA-1pfxC:10.6 | 2vinA-1pfxC:32.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1pq5 | TRYPSIN (Fusariumoxysporum) |
PF00089(Trypsin) | 6 | ASP A 189SER A 190SER A 195VAL A 210GLY A 213GLY A 223 | ARG A 703 (-2.0A)ARG A 703 (-2.5A)ARG A 703 (-2.3A)ARG A 703 (-4.5A)ARG A 703 ( 3.7A)ARG A 703 (-2.6A) | 0.30A | 2vinA-1pq5A:13.7 | 2vinA-1pq5A:33.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q3x | MANNAN-BINDINGLECTIN SERINEPROTEASE 2 (Homo sapiens) |
PF00084(Sushi)PF00089(Trypsin) | 6 | ASP A 627SER A 628SER A 633VAL A 653GLY A 656GLY A 667 | NA A 800 ( 4.6A)GOL A 701 (-3.4A)GOL A 701 (-3.0A)GOL A 701 (-4.9A)GOL A 701 ( 4.1A)GOL A 701 ( 4.0A) | 0.38A | 2vinA-1q3xA:33.2 | 2vinA-1q3xA:26.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1sgf | NERVE GROWTH FACTOR (Mus musculus) |
PF00089(Trypsin) | 4 | ASP G 189SER G 195GLY G 216GLY G 226 | None | 0.59A | 2vinA-1sgfG:13.8 | 2vinA-1sgfG:34.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tnd | TRANSDUCIN (Bos taurus) |
PF00503(G-alpha) | 4 | SER A 40SER A 43GLY A 199GLY A 36 | GSP A 351 (-3.2A) MG A 352 ( 2.2A)GSP A 351 (-3.6A)None | 0.79A | 2vinA-1tndA:undetectable | 2vinA-1tndA:22.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1uuf | ZINC-TYPE ALCOHOLDEHYDROGENASE-LIKEPROTEIN YAHK (Escherichiacoli) |
PF00107(ADH_zinc_N)PF08240(ADH_N) | 4 | GLN A 147VAL A 153GLY A 66GLY A 85 | None | 0.73A | 2vinA-1uufA:undetectable | 2vinA-1uufA:18.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1via | SHIKIMATE KINASE (Campylobacterjejuni) |
PF01202(SKI) | 4 | SER A 15SER A 18GLY A 82GLY A 11 | NoneNoneSO4 A 176 (-3.4A)None | 0.76A | 2vinA-1viaA:undetectable | 2vinA-1viaA:20.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vlp | NICOTINATEPHOSPHORIBOSYLTRANSFERASE (Saccharomycescerevisiae) |
PF04095(NAPRTase) | 5 | SER A 175GLN A 188SER A 214GLY A 354GLY A 352 | NoneNoneNonePO4 A 500 (-3.1A)None | 1.39A | 2vinA-1vlpA:undetectable | 2vinA-1vlpA:21.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xdi | RV3303C-LPDA (Mycobacteriumtuberculosis) |
PF02852(Pyr_redox_dim)PF07992(Pyr_redox_2) | 4 | GLN A 435VAL A 413GLY A 366GLY A 416 | None | 0.74A | 2vinA-1xdiA:undetectable | 2vinA-1xdiA:18.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ybe | NICOTINATEPHOSPHORIBOSYLTRANSFERASE (Agrobacteriumtumefaciens) |
PF04095(NAPRTase) | 5 | SER A 199GLN A 212SER A 231GLY A 370GLY A 368 | None | 1.31A | 2vinA-1ybeA:undetectable | 2vinA-1ybeA:19.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ym0 | FIBRINOTIC ENZYMECOMPONENT B (Eisenia fetida) |
PF00089(Trypsin) | 6 | ASP A 189SER A 190GLN A 192SER A 195VAL A 213GLY A 226 | None | 0.67A | 2vinA-1ym0A:36.0 | 2vinA-1ym0A:33.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ym0 | FIBRINOTIC ENZYMECOMPONENT B (Eisenia fetida) |
PF00089(Trypsin) | 6 | ASP A 189SER A 190SER A 195VAL A 213GLY A 216GLY A 226 | None | 0.33A | 2vinA-1ym0A:36.0 | 2vinA-1ym0A:33.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zca | G ALPHA I/12 (Mus musculus) |
PF00503(G-alpha) | 4 | SER A 66SER A 69GLY A 228GLY A 62 | GDP A 382 (-2.9A) MG A 383 ( 2.1A)ALF A 384 (-3.3A)None | 0.71A | 2vinA-1zcaA:undetectable | 2vinA-1zcaA:20.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1zlr | COAGULATION FACTORXI (Homo sapiens) |
PF00089(Trypsin) | 4 | ASP A 189SER A 195GLY A 216GLY A 226 | 368 A 901 (-2.8A)368 A 901 (-1.4A)368 A 901 (-3.6A)368 A 901 (-3.5A) | 0.39A | 2vinA-1zlrA:10.2 | 2vinA-1zlrA:34.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2a7s | PROBABLEPROPIONYL-COACARBOXYLASE BETACHAIN 5 (Mycobacteriumtuberculosis) |
PF01039(Carboxyl_trans) | 4 | GLN A 213VAL A 196GLY A 152GLY A 154 | None | 0.79A | 2vinA-2a7sA:undetectable | 2vinA-2a7sA:17.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2aip | PROTEIN C ACTIVATOR (Agkistrodoncontortrix) |
PF00089(Trypsin) | 4 | ASP A 189SER A 195GLY A 216GLY A 226 | NoneSO4 A 301 (-2.8A)NoneNone | 0.65A | 2vinA-2aipA:9.4 | 2vinA-2aipA:34.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2eek | TRYPSIN-1 (Gadus morhua) |
PF00089(Trypsin) | 6 | ASP A 189SER A 190SER A 195VAL A 213GLY A 216GLY A 226 | BEN A 301 (-2.7A)BEN A 301 (-2.8A)BEN A 301 (-3.4A)NoneBEN A 301 ( 3.8A)BEN A 301 (-3.2A) | 0.25A | 2vinA-2eekA:16.4 | 2vinA-2eekA:34.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2ei8 | COAGULATION FACTORX, HEAVY CHAIN (Homo sapiens) |
PF00089(Trypsin) | 6 | ASP A 189GLN A 192SER A 195VAL A 213GLY A 216GLY A 226 | DT8 A 700 (-3.5A)DT8 A 700 (-3.9A)DT8 A 700 ( 3.9A)DT8 A 700 ( 4.1A)DT8 A 700 (-3.5A)DT8 A 700 (-3.5A) | 0.47A | 2vinA-2ei8A:14.1 | 2vinA-2ei8A:32.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2f1n | CYTOLETHALDISTENDING TOXINSUBUNIT B (Escherichiacoli) |
PF03372(Exo_endo_phos) | 4 | GLN A 43VAL A 89GLY A 46GLY A 94 | None | 0.66A | 2vinA-2f1nA:undetectable | 2vinA-2f1nA:20.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2f91 | HEPATOPANCREASTRYPSIN (Astacusleptodactylus) |
PF00089(Trypsin) | 6 | ASP A 189SER A 190SER A 195VAL A 213GLY A 216GLY A 227 | None | 0.33A | 2vinA-2f91A:37.1 | 2vinA-2f91A:34.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2i5g | AMIDOHYDROLASE (Pseudomonasaeruginosa) |
PF01244(Peptidase_M19) | 5 | ASP A 135GLN A 118VAL A 169GLY A 128GLY A 137 | None | 1.33A | 2vinA-2i5gA:undetectable | 2vinA-2i5gA:20.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ik8 | GUANINENUCLEOTIDE-BINDINGPROTEIN G(I),ALPHA-1 SUBUNIT (Homo sapiens) |
PF00503(G-alpha) | 4 | SER A 44SER A 47GLY A 203GLY A 40 | GDP A 401 (-3.6A) MG A 356 ( 1.9A)ALF A 355 (-3.3A)None | 0.76A | 2vinA-2ik8A:undetectable | 2vinA-2ik8A:20.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jet | CHYMOTRYPSINOGEN BCHAIN C (Rattusnorvegicus) |
PF00089(Trypsin) | 4 | SER C 195VAL C 213GLY C 216GLY C 226 | None | 0.72A | 2vinA-2jetC:9.7 | 2vinA-2jetC:22.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oq5 | TRANSMEMBRANEPROTEASE, SERINE 11E (Homo sapiens) |
PF00089(Trypsin) | 5 | ASP A 189SER A 195VAL A 213GLY A 216GLY A 226 | BEN A 245 (-3.0A)BEN A 245 (-3.3A)NoneBEN A 245 ( 3.8A)BEN A 245 (-3.4A) | 0.30A | 2vinA-2oq5A:37.0 | 2vinA-2oq5A:35.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2owm | RELATED TOKINESIN-LIKE PROTEINKIF1C (Neurosporacrassa) |
PF00225(Kinesin) | 4 | SER A 148SER A 151GLY A 302GLY A 144 | ADP A1002 (-3.4A) MG A1001 ( 1.9A)NoneNone | 0.70A | 2vinA-2owmA:undetectable | 2vinA-2owmA:19.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pks | THROMBIN HEAVY CHAINFRAGMENT (Homo sapiens) |
PF00089(Trypsin) | 5 | ASP C 229SER C 235VAL C 255GLY C 258GLY C 268 | G44 C 101 (-2.6A)G44 C 101 (-3.5A)NoneG44 C 101 (-3.3A)G44 C 101 (-3.0A) | 0.47A | 2vinA-2pksC:undetectable | 2vinA-2pksC:19.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pnm | PROTEASE VP4 (Infectiouspancreaticnecrosis virus) |
PF01768(Birna_VP4) | 4 | GLN A 635VAL A 589GLY A 593GLY A 591 | None | 0.77A | 2vinA-2pnmA:undetectable | 2vinA-2pnmA:20.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2psy | KALLIKREIN-5 (Homo sapiens) |
PF00089(Trypsin) | 6 | ASP A 189SER A 190SER A 195VAL A 213GLY A 216GLY A 226 | None | 0.43A | 2vinA-2psyA:10.3 | 2vinA-2psyA:35.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q3f | RAS-RELATEDGTP-BINDING PROTEIND (Homo sapiens) |
PF04670(Gtr1_RagA) | 4 | SER A 54SER A 57GLY A 101GLY A 50 | GNP A 401 (-3.5A) MG A 301 ( 2.1A)GNP A 401 (-3.2A)None | 0.75A | 2vinA-2q3fA:undetectable | 2vinA-2q3fA:19.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qi9 | VITAMIN B12 IMPORTSYSTEM PERMEASEPROTEIN BTUC (Escherichiacoli) |
PF01032(FecCD) | 5 | SER A 94SER A 246VAL A 243GLY A 254GLY A 89 | None | 1.37A | 2vinA-2qi9A:undetectable | 2vinA-2qi9A:22.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2qy0 | COMPLEMENT C1RSUBCOMPONENT (Homo sapiens) |
PF00089(Trypsin) | 6 | ASP B 631GLN B 634SER B 637VAL B 657GLY B 660GLY B 668 | None | 0.60A | 2vinA-2qy0B:31.1 | 2vinA-2qy0B:30.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r0l | HEPATOCYTE GROWTHFACTOR ACTIVATOR (Homo sapiens) |
PF00089(Trypsin) | 5 | ASP A 189GLN A 192SER A 195GLY A 216GLY A 226 | None | 0.51A | 2vinA-2r0lA:37.4 | 2vinA-2r0lA:38.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r2w | PLASMINOGENACTIVATOR, UROKINASE (Homo sapiens) |
PF00089(Trypsin) | 5 | ASP U 189SER U 190VAL U 213GLY U 216GLY U 226 | 4PG U 300 (-2.8A)4PG U 300 (-2.7A)None4PG U 300 (-3.3A)4PG U 300 (-3.2A) | 0.31A | 2vinA-2r2wU:46.7 | 2vinA-2r2wU:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r2w | PLASMINOGENACTIVATOR, UROKINASE (Homo sapiens) |
PF00089(Trypsin) | 4 | SER U 190SER U 195VAL U 213GLY U 216 | 4PG U 300 (-2.7A)4PG U 300 (-3.5A)None4PG U 300 (-3.3A) | 0.77A | 2vinA-2r2wU:46.7 | 2vinA-2r2wU:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2wpm | COAGULATION FACTORIXA HEAVY CHAIN (Homo sapiens) |
PF00089(Trypsin) | 5 | ASP S 189SER S 190SER S 195GLY S 216GLY S 226 | None | 0.30A | 2vinA-2wpmS:15.3 | 2vinA-2wpmS:30.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xa7 | ADAPTOR-RELATEDPROTEIN COMPLEX 2,ALPHA 2 SUBUNIT (Rattusnorvegicus) |
PF01602(Adaptin_N) | 4 | GLN A 476VAL A 483GLY A 505GLY A 501 | None | 0.68A | 2vinA-2xa7A:undetectable | 2vinA-2xa7A:17.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xtz | GUANINENUCLEOTIDE-BINDINGPROTEIN ALPHA-1SUBUNIT (Arabidopsisthaliana) |
PF00503(G-alpha) | 4 | SER A 49SER A 52GLY A 221GLY A 45 | GSP A1382 (-3.4A) MG A1381 ( 2.0A)GSP A1382 (-3.4A)None | 0.70A | 2vinA-2xtzA:undetectable | 2vinA-2xtzA:22.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ycb | CLEAVAGE ANDPOLYADENYLATIONSPECIFICITY FACTOR (Methanothermobacterthermautotrophicus) |
PF07521(RMMBL)PF10996(Beta-Casp)PF16661(Lactamase_B_6)PF17214(KH_7) | 5 | SER A 65SER A 68VAL A 69CYH A 100GLY A 128 | None | 1.46A | 2vinA-2ycbA:undetectable | 2vinA-2ycbA:16.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2zec | TRYPTASE BETA 2 (Homo sapiens) |
PF00089(Trypsin) | 7 | ASP A 203SER A 204GLN A 206SER A 209VAL A 227GLY A 230GLY A 240 | 11N A 1 (-2.6A)11N A 1 (-3.5A)None11N A 1 (-3.3A)None11N A 1 (-3.9A)11N A 1 (-3.6A) | 0.36A | 2vinA-2zecA:34.4 | 2vinA-2zecA:35.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3aqp | PROBABLE SECDFPROTEIN-EXPORTMEMBRANE PROTEIN (Thermusthermophilus) |
PF02355(SecD_SecF)PF07549(Sec_GG) | 4 | SER A 634VAL A 601GLY A 704GLY A 708 | None | 0.72A | 2vinA-3aqpA:undetectable | 2vinA-3aqpA:15.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3beu | TRYPSIN (Streptomycesgriseus) |
PF00089(Trypsin) | 6 | ASP A 189GLN A 192SER A 195VAL A 213GLY A 216GLY A 226 | BEN A 247 (-3.0A)SO4 A 246 ( 4.1A)SO4 A 246 ( 2.5A)NoneBEN A 247 (-3.7A)BEN A 247 (-3.5A) | 0.76A | 2vinA-3beuA:32.1 | 2vinA-3beuA:29.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bu1 | LIPOCALIN (Argasmonolakensis) |
PF02098(His_binding) | 5 | ASP A 94SER A 88SER A 8VAL A 7GLY A 15 | HSM A 301 (-2.9A)NoneNoneNoneNone | 1.34A | 2vinA-3bu1A:undetectable | 2vinA-3bu1A:19.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3clj | PROTEIN NRD1 (Saccharomycescerevisiae) |
PF04818(CTD_bind) | 5 | SER A 60SER A 116GLY A 64CYH A 57GLY A 23 | None | 1.37A | 2vinA-3cljA:undetectable | 2vinA-3cljA:21.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cx6 | GUANINENUCLEOTIDE-BINDINGPROTEIN ALPHA-13SUBUNIT (Mus musculus) |
PF00503(G-alpha) | 4 | SER A 59SER A 62GLY A 225GLY A 55 | GDP A 775 (-3.4A) MG A 675 ( 2.7A)NoneNone | 0.70A | 2vinA-3cx6A:undetectable | 2vinA-3cx6A:21.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cx6 | GUANINENUCLEOTIDE-BINDINGPROTEIN ALPHA-13SUBUNIT (Mus musculus) |
PF00503(G-alpha) | 5 | SER A 268SER A 248VAL A 247GLY A 57GLY A 55 | NoneNoneNoneGDP A 775 ( 4.2A)None | 1.21A | 2vinA-3cx6A:undetectable | 2vinA-3cx6A:21.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dqg | HEAT SHOCK 70 KDAPROTEIN F (Caenorhabditiselegans) |
PF00012(HSP70) | 4 | GLN A 522VAL A 497GLY A 519GLY A 517 | None | 0.78A | 2vinA-3dqgA:undetectable | 2vinA-3dqgA:19.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3f6u | VITAMIN K-DEPENDENTPROTEIN C HEAVYCHAIN (Homo sapiens) |
PF00089(Trypsin) | 5 | ASP H 189SER H 195VAL H 213GLY H 216GLY H 226 | 0G6 H 1 (-2.8A)0G6 H 1 (-1.8A)None0G6 H 1 (-3.8A)0G6 H 1 ( 3.9A) | 0.48A | 2vinA-3f6uH:33.3 | 2vinA-3f6uH:35.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gaf | 7-ALPHA-HYDROXYSTEROID DEHYDROGENASE (Brucellaabortus) |
PF13561(adh_short_C2) | 4 | SER A 145VAL A 166GLY A 160GLY A 149 | None | 0.67A | 2vinA-3gafA:undetectable | 2vinA-3gafA:21.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3gov | MASP-1 (Homo sapiens) |
PF00089(Trypsin) | 5 | ASP B 640SER B 646VAL B 666GLY B 669GLY B 679 | None | 0.64A | 2vinA-3govB:34.3 | 2vinA-3govB:30.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3gym | PROSTASIN (Homo sapiens) |
PF00089(Trypsin) | 5 | ASP A 189SER A 195VAL A 213GLY A 216GLY A 226 | None | 0.48A | 2vinA-3gymA:34.5 | 2vinA-3gymA:36.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h7l | ENDOGLUCANASE (Vibrioparahaemolyticus) |
PF00759(Glyco_hydro_9)PF02927(CelD_N) | 4 | GLN A 110VAL A 166GLY A 137GLY A 198 | None | 0.70A | 2vinA-3h7lA:undetectable | 2vinA-3h7lA:16.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hur | ALANINE RACEMASE (Oenococcus oeni) |
PF00842(Ala_racemase_C)PF01168(Ala_racemase_N) | 4 | GLN A 226SER A 229GLY A 44GLY A 46 | SO4 A 395 (-4.6A)NoneNoneNone | 0.76A | 2vinA-3hurA:undetectable | 2vinA-3hurA:21.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jwj | HEN1 (Trichormusvariabilis) |
PF08242(Methyltransf_12) | 5 | ASP A 311SER A 316GLN A 321GLY A 292GLY A 290 | None | 1.40A | 2vinA-3jwjA:undetectable | 2vinA-3jwjA:22.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3m49 | TRANSKETOLASE (Bacillusanthracis) |
PF00456(Transketolase_N)PF02779(Transket_pyr)PF02780(Transketolase_C) | 5 | ASP A 159SER A 169GLY A 121CYH A 155GLY A 119 | None | 1.42A | 2vinA-3m49A:undetectable | 2vinA-3m49A:15.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n6z | PUTATIVEIMMUNOGLOBULIN A1PROTEASE (Bacteroidesovatus) |
no annotation | 4 | SER A 290SER A 224GLY A 239GLY A 270 | None | 0.72A | 2vinA-3n6zA:undetectable | 2vinA-3n6zA:19.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3r3g | THROMBIN HEAVY CHAIN (Homo sapiens) |
PF00089(Trypsin) | 5 | ASP B 189SER B 195VAL B 213GLY B 216GLY B 226 | None | 0.45A | 2vinA-3r3gB:34.6 | 2vinA-3r3gB:31.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3r7w | GTP-BINDING PROTEINGTR1 (Saccharomycescerevisiae) |
PF04670(Gtr1_RagA) | 4 | SER A 17SER A 20GLY A 64GLY A 13 | GNP A 500 (-3.6A) MG A 600 ( 2.0A)GNP A 500 (-3.8A)None | 0.76A | 2vinA-3r7wA:undetectable | 2vinA-3r7wA:20.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3s69 | THROMBIN-LIKE ENZYMEDEFIBRASE (Gloydiussaxatilis) |
PF00089(Trypsin) | 5 | ASP A 189SER A 195VAL A 209GLY A 212GLY A 223 | None | 0.60A | 2vinA-3s69A:9.3 | 2vinA-3s69A:29.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w6o | DYNAMIN-1-LIKEPROTEIN (Homo sapiens) |
PF00350(Dynamin_N)PF01031(Dynamin_M) | 4 | SER A 36SER A 39GLY A 149GLY A 32 | GCP A 801 (-4.0A) MG A 802 ( 2.0A)GCP A 801 (-3.6A)None | 0.79A | 2vinA-3w6oA:undetectable | 2vinA-3w6oA:21.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3w94 | ENTEROPEPTIDASE-1 (Oryzias latipes) |
PF00089(Trypsin) | 6 | ASP A 973SER A 974GLN A 976SER A 979GLY A1000GLY A1010 | None | 0.53A | 2vinA-3w94A:37.1 | 2vinA-3w94A:33.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zjc | GTPASE IMAP FAMILYMEMBER 7 (Homo sapiens) |
PF04548(AIG1) | 4 | SER A 19SER A 22GLY A 66GLY A 15 | GNP A1297 (-3.9A) MG A1296 ( 2.4A)GNP A1297 ( 4.3A)None | 0.69A | 2vinA-3zjcA:undetectable | 2vinA-3zjcA:21.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bxw | FACTOR XA (Pseudonajatextilis) |
PF00089(Trypsin)PF14670(FXa_inhibition) | 5 | ASP A 356SER A 362VAL A 380GLY A 383GLY A 393 | 0GJ A1411 (-2.7A)0GJ A1411 (-1.4A)None0GJ A1411 (-3.7A)0GJ A1411 (-3.3A) | 0.40A | 2vinA-4bxwA:9.5 | 2vinA-4bxwA:22.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ci8 | ECHINODERMMICROTUBULE-ASSOCIATED PROTEIN-LIKE 1 (Homo sapiens) |
PF00400(WD40)PF03451(HELP) | 5 | ASP A 647SER A 645GLN A 588GLY A 606GLY A 625 | None | 1.39A | 2vinA-4ci8A:undetectable | 2vinA-4ci8A:17.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4d9r | COMPLEMENT FACTOR D (Homo sapiens) |
PF00089(Trypsin) | 5 | ASP A 189SER A 190SER A 195VAL A 213GLY A 226 | None | 0.63A | 2vinA-4d9rA:13.8 | 2vinA-4d9rA:32.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dgj | ENTEROPEPTIDASECATALYTIC LIGHTCHAIN (Homo sapiens) |
PF00089(Trypsin) | 4 | ASP A 181SER A 182GLY A 208GLY A 218 | None | 0.29A | 2vinA-4dgjA:37.0 | 2vinA-4dgjA:34.60 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4fxg | MANNAN-BINDINGLECTIN SERINEPROTEASE 2 B CHAIN (Homo sapiens) |
PF00089(Trypsin) | 5 | ASP H 627SER H 628VAL H 653GLY H 656GLY H 667 | None | 0.41A | 2vinA-4fxgH:33.5 | 2vinA-4fxgH:31.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4gso | THROMBIN-LIKE ENZYMEBJUSSUSP-1 (Bothropsjararacussu) |
PF00089(Trypsin) | 5 | ASP A 172SER A 178VAL A 192GLY A 195GLY A 206 | None | 0.65A | 2vinA-4gsoA:undetectable | 2vinA-4gsoA:31.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4iw4 | MANNAN-BINDINGLECTIN SERINEPROTEASE 3 (Homo sapiens) |
PF00089(Trypsin) | 5 | ASP E 639SER E 645VAL E 665GLY E 668GLY E 680 | None | 0.39A | 2vinA-4iw4E:33.0 | 2vinA-4iw4E:30.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4izk | YELLOWTAIL ASCITESVIRUS (YAV) VP4PROTEASE (Yellowtailascites virus) |
PF01768(Birna_VP4) | 4 | GLN A 635VAL A 589GLY A 593GLY A 591 | None | 0.71A | 2vinA-4izkA:undetectable | 2vinA-4izkA:21.01 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4k8y | KALLIKREIN-4 (Homo sapiens) |
PF00089(Trypsin) | 6 | ASP A 189SER A 190SER A 195VAL A 213GLY A 216GLY A 226 | None | 0.38A | 2vinA-4k8yA:16.2 | 2vinA-4k8yA:33.85 |